GoalVest Advisory »

Immunitybio shares owned by GoalVest Advisory

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by GoalVest Advisory from 13F filings

Historical chart of GoalVest Advisory investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by GoalVest Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by GoalVest Advisory

Quarter filed Position value Share count Share price at filing
2026-03-31 $3.8k 500 7.67

More positions owned by GoalVest Advisory

Vanguard S&p 500 Etf Etf (VOO)
Vanguard Growth Etf Etf (VUG)
State Street Spdr Portfolio Intermediate Term Corporate Bond Etf Etf (SPIB)
Goldman Sachs Municipal Income Etf Etf (GMUB)
State Street Spdr Nyse Technology Etf Etf (XNTK)
Ishares Core Msci Eafe Etf Etf (IEFA)
Vanguard Total Stock Market Etf Etf (VTI)
Vanguard Ftse Europe Etf Etf (VGK)
Goldman Sachs Physical Gold Etf Etf (AAAU)
Ishares Core Msci Emerging Markets Etf Etf (IEMG)
Nvidia Corporation Stock (NVDA)
Alphabet Inc Cap Stk Cl A Stock (GOOGL)
Microsoft Corp Stock (MSFT)
Spear Alpha Etf Etf (SPRX)
Palantir Technologies Inc Cl A Stock (PLTR)

View all positions for GoalVest Advisory

Top funds holding Immunitybio

Vanguard Group
BlackRock
State Street Corporation
Jane Street
Geode Capital Management
Goldman Sachs Group
Susquehanna International
Two Sigma Investments
Woodline Partners
AlphaCore Capital
Charles Schwab Investment Management
Barclays
Tang Capital Management
Northern Trust
UBS Group

View all funds holding Immunitybio